Maintenance contract on a government owned CFX 384 well real time Q-PCR system and CFX 96 well optical module
Ended Awarded Last action
- Contract number
- 75N91023F00001
- Awardee
-
Bio-Rad Laboratories, Inc. UEI SSHPDYFGN7J9 Part of Bio-Rad Laboratories, Inc.
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $10,704
Award facts
- Contract value 100% obligated
- $10,704.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Bethesda, MD 20892, USA
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
Award details come from SAM.gov/FPDS.
About this award
Bio-Rad Laboratories, Inc.'s Life Science Group Division was awarded a maintenance contract valued at $10,704 by the National Cancer Institute for the servicing and upkeep of government-owned CFX 384-well and CFX 96-well optical module real-time quantitative polymerase chain reaction (Q-PCR) systems. The contract, awarded July 17, 2023, with completion targeted for July 16, 2024, was issued as a call against a Blanket Purchase Agreement under a firm fixed-price arrangement. The work is to be performed at the National Cancer Institute's facility in Bethesda, Maryland. This award was not designated as a small business set-aside, reflecting Bio-Rad's established position as a large federal contractor specializing in advanced laboratory instrumentation and scientific equipment.
The maintenance engagement supports critical research infrastructure at one of the nation's premier cancer research institutions. Bio-Rad, headquartered in Hercules, California, is a global leader in life science research and clinical diagnostics with an extensive track record of supplying sophisticated laboratory technologies to federal agencies including the National Institutes of Health, Centers for Disease Control and Prevention, and the Department of Veterans Affairs. The company maintains a $10 million BPA with the NIH Office of Logistics and Acquisition Operations through December 31, 2025, which enables efficient procurement of specialized laboratory equipment and supplies across multiple NIH institutes, positioning Bio-Rad as a critical partner in supporting federal biomedical research capabilities.
Quick answers
Who was awarded contract 75N91023F00001?
75N91023F00001 was awarded to Bio-Rad Laboratories, Inc. by National Cancer Institute (National Institutes of Health) on July 17, 2023.
How much is contract 75N91023F00001 worth?
The government has obligated $10,704 on 75N91023F00001.
Is contract 75N91023F00001 an order under another contract?
Yes. 75N91023F00001 is a BPA call under HHSN263201500172B, a blanket purchase agreement.
Was contract 75N91023F00001 competed?
The extent of competition for 75N91023F00001 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award